Literature DB >> 2009539

Development of invasive and growth factor-independent cell variants from primary human melanomas.

R Kath1, J A Jambrosic, L Holland, U Rodeck, M Herlyn.   

Abstract

Growth autonomy and high levels of invasiveness are characteristics of human melanoma cells that are metastatic in vivo. By consecutive passage through a reconstructed basement membrane, we have selected from 5 of 6 primary melanoma cell lines variants which show an up to 10-fold increase in invasiveness. The invasive variants grew more rapidly than the parental, noninvasive cells in serum- and growth factor-free medium and one of the 3 variant cell lines with the highest invasive capacity in vitro metastasized to the lungs when injected s.c. into nude mice. In a second approach, variants of 6 primary melanoma cell lines were clonally selected in medium without exogenous growth factors (protein-free medium). These selected cells showed higher invasive properties in vitro and in vivo than the parental cells. Clones of invasive and growth factor-independent cell variants were heterogenous and changed over time in the absence of selected pressure to a phenotype similar to that of parental nonselected cells. These results indicate that primary melanoma cells contain subpopulations of cells that have the phenotype of an advanced (metastatic) stage of tumor progression, but this phenotype is not stable without selective pressure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2009539

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Tumor-associated antigen expression and growth requirements predict tumorigenesis in squamous cell carcinoma.

Authors:  E R Salter; D Tichansky; E E Furth; A M Herlyn
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

2.  Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma.

Authors:  M Y Hsu; D T Shih; F E Meier; P Van Belle; J Y Hsu; D E Elder; C A Buck; M Herlyn
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

3.  Aberrations of growth factor control in metastatic follicular thyroid cancer in vitro.

Authors:  T Hoelting; A Zielke; A E Siperstein; O H Clark; Q Y Duh
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

4.  Characterisation of breast cancer cell lines and establishment of a novel isogenic subclone to study migration, invasion and tumourigenicity.

Authors:  Linda Hughes; Catherine Malone; Saranya Chumsri; Angelika M Burger; Susan McDonnell
Journal:  Clin Exp Metastasis       Date:  2008-04-02       Impact factor: 5.150

Review 5.  [Relevance of cell culture models in cutaneous tumour biology: part II: complex culture systems].

Authors:  J Hatina; T Ruzicka
Journal:  Hautarzt       Date:  2008-02       Impact factor: 0.751

6.  Differential purification of autocrine motility factor derived from a murine protein-free fibrosarcoma.

Authors:  H Watanabe; K Kanbe; M Chigira
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

7.  Variant sublines of early-stage human melanomas selected for tumorigenicity in nude mice express a multicytokine-resistant phenotype.

Authors:  H Kobayashi; S Man; J R MacDougall; C H Graham; C Lu; R S Kerbel
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

Review 8.  Potential contributions of antimutator activity to the metastasis suppressor function of NM23-H1.

Authors:  David M Kaetzel; Joseph R McCorkle; Marian Novak; Mengmeng Yang; Stuart G Jarrett
Journal:  Mol Cell Biochem       Date:  2009-04-21       Impact factor: 3.396

Review 9.  From melanocytes to melanomas.

Authors:  A Hunter Shain; Boris C Bastian
Journal:  Nat Rev Cancer       Date:  2016-04-29       Impact factor: 60.716

10.  Growth and invasion of human melanomas in human skin grafted to immunodeficient mice.

Authors:  I Juhasz; S M Albelda; D E Elder; G F Murphy; K Adachi; D Herlyn; I T Valyi-Nagy; M Herlyn
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.